Jared Gollob - Chief Medical Officer at Kymera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
KYMR on Nasdaq
All Insider Reports
All Insider Reports

Jared Gollob - trading volume in the past year for Kymera Therapeutics, Inc.

Holdings reported by Jared Gollob for Kymera Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 117,134 $10,146,697 $86.62 04 Mar 2026 Direct
Stock Option (Right to Buy) 35,300 02 Mar 2026 Direct Common Stock

Transactions reported by Jared Gollob for Kymera Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.